Stay updated on OMS721 Compassionate Use in TMA Clinical Trial
Sign up to get notified when there's something new on the OMS721 Compassionate Use in TMA Clinical Trial page.

Latest updates to the OMS721 Compassionate Use in TMA Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check21 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a compassionate use study for patients with thrombotic microangiopathy and the addition of a new version revision. The principal investigator's name has also been included.SummaryDifference22%
- Check28 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
- Check36 days agoNo Change Detected
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference3%
- Check86 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference3%
- Check93 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.2%
Stay in the know with updates to OMS721 Compassionate Use in TMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OMS721 Compassionate Use in TMA Clinical Trial page.